- Home
- DRTS vs SABA Comparison
DRTS vs SABA Comparison
Compare DRTS & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRTS
- SABA
- Stock Information
- Founded
- DRTS 2015
- SABA 1988
- Country
- DRTS Israel
- SABA United States
- Employees
- DRTS N/A
- SABA N/A
- Industry
- DRTS Medical/Dental Instruments
- SABA
- Sector
- DRTS Health Care
- SABA
- Exchange
- DRTS Nasdaq
- SABA Nasdaq
- Market Cap
- DRTS 300.2M
- SABA 252.3M
- IPO Year
- DRTS N/A
- SABA N/A
- Fundamental
- Price
- DRTS $3.80
- SABA $8.66
- Analyst Decision
- DRTS Strong Buy
- SABA
- Analyst Count
- DRTS 1
- SABA 0
- Target Price
- DRTS $9.00
- SABA N/A
- AVG Volume (30 Days)
- DRTS 64.9K
- SABA 290.0K
- Earning Date
- DRTS 11-18-2025
- SABA 01-01-0001
- Dividend Yield
- DRTS N/A
- SABA 12.91%
- EPS Growth
- DRTS N/A
- SABA N/A
- EPS
- DRTS N/A
- SABA N/A
- Revenue
- DRTS N/A
- SABA N/A
- Revenue This Year
- DRTS N/A
- SABA N/A
- Revenue Next Year
- DRTS N/A
- SABA N/A
- P/E Ratio
- DRTS N/A
- SABA N/A
- Revenue Growth
- DRTS N/A
- SABA N/A
- 52 Week Low
- DRTS $2.14
- SABA $3.64
- 52 Week High
- DRTS $4.69
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- DRTS 41.23
- SABA 40.85
- Support Level
- DRTS $3.75
- SABA $8.52
- Resistance Level
- DRTS $4.07
- SABA $8.92
- Average True Range (ATR)
- DRTS 0.23
- SABA 0.11
- MACD
- DRTS -0.03
- SABA 0.01
- Stochastic Oscillator
- DRTS 1.27
- SABA 45.00
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.